Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
about
Emerging Threats in Antifungal-Resistant Fungal PathogensMechanisms of Candida biofilm drug resistanceAntifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogensEchinocandin resistance: an emerging clinical problem?Antifungal Therapy: New Advances in the Understanding and Treatment of MycosisInvestigating Clinical Issues by Genotyping of Medically Important Fungi: Why and How?Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care centerRegulatory circuitry governing fungal development, drug resistance, and disease.Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species.Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patientsDevelopment of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment.Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France.Candida spp. with acquired echinocandin resistance, France, 2004-2010.Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.Comparison of dimethyl sulfoxide and water as solvents for echinocandin susceptibility testing by the EUCAST methodology.Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrationsBiofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposureBreakthrough Aspergillus fumigatus and Candida albicans double infection during caspofungin treatment: laboratory characteristics and implication for susceptibility testing.Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance.Fluconazole and Echinocandin Resistance of Candida glabrata Correlates Better with Antifungal Drug Exposure Rather than with MSH2 Mutator Genotype in a French Cohort of Patients Harboring Low Rates of Resistance.Current perspectives on echinocandin class drugs.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011.Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes.The risk and clinical outcome of candidemia depending on underlying malignancy.Mechanisms of antifungal drug resistance in Candida dubliniensis.Whole Genome Sequence of the Heterozygous Clinical Isolate Candida krusei 81-B-5.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling.Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species.Echinocandin Resistance in Candida Species Isolates from Liver Transplant Recipients.Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strainsEchinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei.Fks1 and Fks2 are functionally redundant but differentially regulated in Candida glabrata: implications for echinocandin resistance.
P2860
Q26750816-69BE7006-BBDF-4D6D-BBB7-C204FDB0C9FCQ26827521-D3847772-F2BA-445B-BAD2-C7AFEA65A021Q28481349-BF9AE66D-BC6A-4883-B914-97A7955774EEQ28544739-6AD9CACD-B788-4810-9F3D-BEAB858848C7Q28818603-9FC66AF9-5B7D-4795-9189-4B995D4E3EF3Q29994504-D6851B2C-5BF8-4FB4-AED5-9E49D280EE5BQ34058322-BE9A6F02-2D66-4852-98A2-FDF6E8DFB1B7Q34190284-9333693C-B0F2-4F59-A8B0-5AA4E63F6922Q34246802-261B032B-C6FD-4279-830C-FD9DA460E45AQ34529026-4F31C07C-0566-4235-83EE-38925D53625EQ35066753-855B1FD3-8487-415F-A940-E4CF76D0D60EQ35363662-F1434D8D-F3D5-431B-B8DE-37C4615C29E9Q35845865-8CF2AC85-D085-40FE-833C-3DD704F0C1E2Q35941237-C4420260-5968-43DF-8EAA-5454D883EDE9Q36118827-31E9EA95-1916-4AAB-B5FC-8E9BED2A04A1Q36158489-B2A7973F-4FF0-4FCD-8F08-925F615C5E94Q36290663-742FDB9D-9566-4BAD-85FA-283D0C4F5968Q36505494-A3AFA0DD-78BB-4D34-8993-654D50A78DA7Q36856930-89268068-7361-4CB8-9F2D-55DC24D3E696Q36933366-E35D4955-0161-4458-A114-ED29F47891C3Q37036603-7F4AAC0F-6EA9-439E-A949-3868FD4D2E3FQ37115801-888836EC-D179-4946-8C22-315E68C75136Q37263358-C6082E8B-2CAD-4295-971D-8D2F3B38F643Q37335747-97381D88-6772-4D20-849B-1EF51477F201Q37500666-B344AEA7-D2A1-445D-8ECB-DC36B55E8E03Q37528498-067D7085-143E-4A5F-9C82-228B724B22D4Q37554055-73D6859F-E3AA-4624-BEEC-98C4A60BE6E2Q37608276-6B0A7128-07C2-4087-8C5D-EE97F2B8ED6BQ37643602-33DFC48D-A36E-4A8F-8FB8-851464587995Q37694014-22070500-76AD-44B8-B982-504D66BD13B9Q37742252-F1D0DFB8-6E53-48D1-8528-8DA02D4637CAQ37762556-B975D690-74DB-4BEA-9608-85F2351A418DQ38684199-A5FCFA0D-541D-4D52-ACCD-1A3C4DB0017BQ38711698-EADBD7E2-7265-45AF-85D3-9AD9A083CF4DQ40323063-F32B9778-97FF-4847-978C-0E44856BD50DQ40345973-90251D1A-A08A-4903-812E-93FDE6C63B82Q40448192-73D12403-4362-44F9-A084-7B83FCCE9D39Q40750655-0951CB10-38CD-4EA4-88F7-40745FE6AB4DQ41075366-916F7D1E-CFD4-4B5B-BF3C-737CE9F3191EQ41184732-9ED3DABF-B461-4333-B0BB-9868BF5DD2DF
P2860
Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mutations in the fks1 gene in ...... biotic Susceptibility Testing.
@en
type
label
Mutations in the fks1 gene in ...... biotic Susceptibility Testing.
@en
prefLabel
Mutations in the fks1 gene in ...... biotic Susceptibility Testing.
@en
P2093
P2860
P356
P1476
Mutations in the fks1 gene in ...... biotic Susceptibility Testing.
@en
P2093
Damien Hoinard
Dorothée Raoux
European Committee on Antibiotic Susceptibility Testing
Françoise Dromer
Marie Desnos-Ollivier
P2860
P304
P356
10.1128/AAC.00088-08
P407
P577
2008-06-30T00:00:00Z